Search for Clinical Trial Results

Sponsored By

Carcinoma, Islet Cell - 21 Studies Found

Status Study
Completed Study Name: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma
Condition:
  • Metastatic Gastrointestinal Carcinoid Tumor
  • Pulmonary Carcinoid Tumor
  • Drug: temsirolimus Given IV
Completed Study Name: Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
Condition:
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor
  • Lung Can
    Date: 2001-12-07
    Interventions: Drug: thalidomide
Completed Study Name: Clinical Evaluation of i-STAT Analyzer
Condition:
  • Diabetes Mellitus
  • Neonatal Hypoglycemia
  • Pancreatic Date: 2016-07-06
Active, not recruiting Study Name: Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
Condition:
  • Pancreatic Gastrinoma
  • Pancreatic Neuroendocrine Tumor G1
  • P
    Date: 2010-10-27
    Interventions:
    • Biological: Bevacizumab Given

Active, not recruiting Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Drug: temozolomide Given PO
Withdrawn Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Drug: dovitinib lactate Given

Terminated Study Name: Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Drug: everolimus Given PO
Active, not recruiting Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Drug: capecitabine Given PO
Completed Study Name: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma
  • Drug: regorafenib Given PO
Completed Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
Condition:
  • Gastrinoma
  • Glucagonoma
  • Insulinoma